BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18056459)

  • 1. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET.
    Brest P; Gustafsson M; Mossberg AK; Gustafsson L; Duringer C; Hamiche A; Svanborg C
    Cancer Res; 2007 Dec; 67(23):11327-34. PubMed ID: 18056459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
    Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors.
    Ellis DJ; Lawman ZK; Bonham K
    Biochem Biophys Res Commun; 2008 Mar; 367(3):656-62. PubMed ID: 18179771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells.
    Kumar KS; Sonnemann J; Beck JF
    Oncol Rep; 2006 Nov; 16(5):1047-52. PubMed ID: 17016591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN
    J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.
    Sonnemann J; Hüls I; Sigler M; Palani CD; Hong le TT; Völker U; Kroemer HK; Beck JF
    Oncol Rep; 2008 Jul; 20(1):219-24. PubMed ID: 18575740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells.
    Rao J; Bhattacharya D; Banerjee B; Sarin A; Shivashankar GV
    Biochem Biophys Res Commun; 2007 Nov; 363(2):263-8. PubMed ID: 17869223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
    Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
    Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments.
    Karagiannis TC; Harikrishnan KN; El-Osta A
    Oncogene; 2007 Jun; 26(27):3963-71. PubMed ID: 17213813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
    Suzuki T; Matsuura A; Kouketsu A; Hisakawa S; Nakagawa H; Miyata N
    Bioorg Med Chem; 2005 Jul; 13(13):4332-42. PubMed ID: 15927839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
    Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
    Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation.
    Rho JH; Kang DY; Park KJ; Choi HJ; Lee HS; Yee SB; Yoo YH
    Int J Oncol; 2005 Aug; 27(2):465-71. PubMed ID: 16010429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
    Rahim R; Strobl JS
    Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
    Kouraklis G; Theocharis S
    Oncol Rep; 2006 Feb; 15(2):489-94. PubMed ID: 16391874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No need to be HAMLET or BAMLET to interact with histones: binding of monomeric alpha-lactalbumin to histones and basic poly-amino acids.
    Permyakov SE; Pershikova IV; Khokhlova TI; Uversky VN; Permyakov EA
    Biochemistry; 2004 May; 43(19):5575-82. PubMed ID: 15134431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors as anti-neoplastic agents.
    Batty N; Malouf GG; Issa JP
    Cancer Lett; 2009 Aug; 280(2):192-200. PubMed ID: 19345475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin.
    Tóth KF; Knoch TA; Wachsmuth M; Frank-Stöhr M; Stöhr M; Bacher CP; Müller G; Rippe K
    J Cell Sci; 2004 Aug; 117(Pt 18):4277-87. PubMed ID: 15292402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.